INNO-GENE SA ZY -10 (F:WQ3) — Stock Price
INNO-GENE SA ZY -10 (F:WQ3) is currently trading at €0.38 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.38 and €0.40. This page tracks INNO-GENE SA ZY -10's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of INNO-GENE SA ZY -10.
INNO-GENE SA ZY -10 (WQ3) Stock Price Chart — Daily History & Trading Volume
The chart below tracks INNO-GENE SA ZY -10's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
INNO-GENE SA ZY -10 Income Statement — Revenue, Profit & Earnings by Year
INNO-GENE SA ZY -10's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | €3.30 Million | €1.13 Million | €16.44 Million | €29.95 Million |
| Cost of Revenue | €10.88K | €685.31K | €2.87 Million | €7.49 Million |
| Gross Profit | €3.29 Million | €442.68K | €13.57 Million | €22.45 Million |
| Research & Development | — | — | — | — |
| SG&A | — | — | — | €7.71 Million |
| Total Operating Expenses | €1.38 Million | €3.65 Million | €17.35 Million | €19.31 Million |
| Operating Income | €1.59 Million | €-2.52 Million | €-910.00K | €10.64 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €19.32K | €15.00K | €11.00K | €14.00K |
| Income Before Tax | €95.14K | €-5.32 Million | €768.00K | €8.41 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €18.85K | €-6.22 Million | €315.00K | €6.03 Million |
INNO-GENE SA ZY -10 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes INNO-GENE SA ZY -10's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | €24.52 Million | €5.60 Million | €10.27 Million | €13.45 Million |
| Total Current Assets | €8.07 Million | €3.02 Million | €7.44 Million | €12.31 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €1.59 Million | — | — | — |
| Net Receivables | €5.10 Million | €671.28K | €256.00K | €3.41 Million |
| Inventory | €21.55K | €0.00 | €566.00K | €1.23 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €1.99 Million | €7.05K | — | €0.00 |
| Total Liabilities | €6.50 Million | €3.16 Million | €2.22 Million | €5.60 Million |
| Total Current Liabilities | €6.36 Million | €2.95 Million | €2.08 Million | €5.60 Million |
| Long-term Debt | €0.00 | €0.00 | — | €0.00 |
| Net Debt | €10.55K | — | €221.00K | — |
| Total Stockholder Equity | €18.02 Million | €2.44 Million | €8.05 Million | €7.85 Million |
| Retained Earnings | €-7.18 Million | €-7.19 Million | €-1.58 Million | €-1.78 Million |
INNO-GENE SA ZY -10 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how INNO-GENE SA ZY -10 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | €-1.13 Million | €-2.49 Million | €11.00K | €6.75 Million |
| Capital Expenditures | €45.00K | €0.00 | €0.00 | €82.00K |
| Free Cash Flow | €-1.18 Million | €-2.49 Million | €11.00K | €6.67 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €76.45K | €151.65K | €95.00K | €281.00K |
| Change in Cash | €-21.76K | €127.60K | €-3.77 Million | €3.64 Million |
INNO-GENE SA ZY -10 Earnings History — EPS Actual vs. Analyst Estimates
Track INNO-GENE SA ZY -10's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for INNO-GENE SA ZY -10.